✓ Last verified: February 13, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Relievus Pain Management’s Woodbury Heights location serves Gloucester County with IV ketamine infusion therapy. Part of the statewide Relievus network led by board-certified anesthesiologists, this office provides ketamine treatment near Woodbury and the I-295 corridor in South Jersey.
| Google Reviews | ⭐ Multi-location NJ network |
| Location | Woodbury Heights, New Jersey |
| Address | 750 Mantua Pike, Woodbury Heights, NJ 08097 |
| Phone | (888) 985-2727 |
| Website | relievus.com |
| Treatments | IV Ketamine Infusions, Pain Management |
| Conditions Treated | Depression, Anxiety, PTSD, CRPS, Chronic Pain, Insomnia |
| Cost | Contact clinic for pricing |
| Insurance | Contact clinic for details |
| KAP Available | Not specified |
| Clinical Lead | Dr. Lee & Dr. Purewal (Board-Certified Anesthesiologists) |
HealingMaps Take: The Woodbury Heights location provides another Gloucester County option along the Mantua Pike corridor, convenient for Deptford and Woodbury residents. Confirm ketamine availability at this location when scheduling.
Market Position: Relievus Pain Management is an IV-ketamine-focused clinic in the Woodbury metro — the most common cash-pay protocol in the HealingMaps verified directory.
Industry pricing reference. Relievus Pain Management has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Gloucester County, NJ, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
75% of ketamine patients report zero insurance coverage for their treatment — meaning most patients pay cash and should factor the full cost of care into their treatment decision. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 4-question summary is matched to the protocols and conditions Relievus Pain Management treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Relievus Pain Management treats depression via IV ketamine (off-label, evidence-based). Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Relievus Pain Management treats chronic pain. They use IV ketamine for pain, which typically means longer infusion times and higher cumulative doses than mental-health protocols. Common indications include complex regional pain syndrome (CRPS), fibromyalgia, and certain neuropathic pain syndromes. Pain pricing varies significantly by structure: per-infusion vs. multi-day inpatient packages — verify how this clinic structures their billing.
Yes — Relievus Pain Management treats PTSD. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Relievus Pain Management treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply